Skip to main content

EVOXAC 30 mg Pill - white capsule/oblong, 15mm

Pill with imprint EVOXAC 30 mg is White, Capsule/Oblong and has been identified as Cevimeline hydrochloride 30 mg. It is supplied by Ranbaxy Pharm.

Cevimeline is used in the treatment of Sjogren's Syndrome and belongs to the drug class cholinergic agonists. Risk cannot be ruled out during pregnancy. Cevimeline 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EVOXAC 30 mg

Cevimeline hydrochloride 30 mg EVOXAC 30 mg
Cevimeline hydrochloride 30 mg EVOXAC 30 mg
Cevimeline hydrochloride 30 mg EVOXAC 30 mg

Cevimeline hydrochloride

Imprint
EVOXAC 30 mg
Strength
30 mg
Color
White
Size
15.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cholinergic agonists
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ranbaxy Pharm
Inactive Ingredients
lactose monohydrate, magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
63304-0479 Ranbaxy Pharmaceuticals Inc.
63395-0201 Daiichi Sankyo Inc.
66267-1298 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "EVOXAC 30 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.